Rempex Pharmaceuticals Overview
- Year Founded
-
2011
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$140M
Rempex Pharmaceuticals General Information
Description
Developer of new antibacterial drugs to meet the growing clinical need created by multi-drug resistant bacterial pathogens. The company's internal development pipeline focuses on combining proprietary formulation and potentiating agents with antibiotics to overcome or directly inhibit the molecular mechanisms in bacteria responsible for antibiotic resistance.
Contact Information
Website
www.rempexpharma.comCorporate Office
- 11535 Sorrento Valley Road
- San Diego, CA 92121
- United States
Corporate Office
- 11535 Sorrento Valley Road
- San Diego, CA 92121
- United States
Rempex Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 04-Dec-2013 | $140M | Completed | Clinical Trials - Phase 1 | ||
| 2. Early Stage VC (Series B) | 22-Jan-2013 | Completed | Clinical Trials - Phase 1 | |||
| 1. Early Stage VC (Series A) | 10-Jun-2011 | $8.5M | $8.5M | Completed | Product Development |
Rempex Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Rempex Pharmaceuticals Comparisons
Industry
Financing
Details
Rempex Pharmaceuticals Competitors (21)
One of Rempex Pharmaceuticals’s 21 competitors is Bugworks Research, a Private Equity-Backed company based in Wilmington, DE.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Bugworks Research | Private Equity-Backed | Wilmington, DE | ||||
| Fedora Pharmaceuticals | Venture Capital-Backed | Edmonton, Canada | ||||
| Eligo Bioscience | Venture Capital-Backed | Paris, France | ||||
| Ability Pharma | Private Equity-Backed | Cerdanyola, Spain | ||||
| NovaBiotics | Venture Capital-Backed | Aberdeen, United Kingdom |
Rempex Pharmaceuticals Patents
Rempex Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2019212883-A1 | Methods of treating bacterial infections with minocycline | Inactive | 30-Apr-2018 | ||
| US-11999757-B2 | Synthesis of boronate ester derivatives and uses thereof | Active | 01-Nov-2017 | ||
| US-20190127396-A1 | Synthesis of boronate ester derivatives and uses thereof | Inactive | 01-Nov-2017 | ||
| US-20200308197-A1 | Synthesis of boronate ester derivatives and uses thereof | Active | 01-Nov-2017 | ||
| WO-2019089542-A1 | Synthesis of boronate ester derivatives and uses thereof | Inactive | 01-Nov-2017 | C07C69/675 |
Rempex Pharmaceuticals Former Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Adams Street Partners | PE/Buyout | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| OrbiMed | Growth/Expansion | Minority | ||
| SV Health Investors | PE/Buyout | Minority | ||
| Vivo Capital | Venture Capital | Minority |
Rempex Pharmaceuticals FAQs
-
When was Rempex Pharmaceuticals founded?
Rempex Pharmaceuticals was founded in 2011.
-
Where is Rempex Pharmaceuticals headquartered?
Rempex Pharmaceuticals is headquartered in San Diego, CA.
-
What industry is Rempex Pharmaceuticals in?
Rempex Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Rempex Pharmaceuticals a private or public company?
Rempex Pharmaceuticals is a Private company.
-
What is the current valuation of Rempex Pharmaceuticals?
The current valuation of Rempex Pharmaceuticals is .
-
What is Rempex Pharmaceuticals’s current revenue?
The current revenue for Rempex Pharmaceuticals is .
-
How much funding has Rempex Pharmaceuticals raised over time?
Rempex Pharmaceuticals has raised $76M.
-
Who are Rempex Pharmaceuticals’s investors?
Adams Street Partners, Frazier Healthcare Partners, OrbiMed, SV Health Investors, and Vivo Capital have invested in Rempex Pharmaceuticals.
-
Who are Rempex Pharmaceuticals’s competitors?
Bugworks Research, Fedora Pharmaceuticals, Eligo Bioscience, Ability Pharma, and NovaBiotics are some of the 21 competitors of Rempex Pharmaceuticals.
-
When was Rempex Pharmaceuticals acquired?
Rempex Pharmaceuticals was acquired on 04-Dec-2013.
-
Who acquired Rempex Pharmaceuticals?
Rempex Pharmaceuticals was acquired by The Medicines Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process